Stability and pre-formulation development of a plant-produced anthrax vaccine candidate (Q36258430)

13 August 2017

title

Stability and pre-formulation development of a plant-produced anthrax vaccine candidate (English)

1 reference

13 August 2017

9

Vidadi Yusibov

1 reference

13 August 2017

R Mark Jones

1

1 reference

13 August 2017

Michael Burke

2

1 reference

13 August 2017

Devon Dubose

3

1 reference

13 August 2017

Jessica A Chichester

4

1 reference

13 August 2017

Slobodanka Manceva

5

1 reference

13 August 2017

April Horsey

6

1 reference

13 August 2017

Stephen J Streatfield

7

1 reference

13 August 2017

Jeff Breit

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

20 January 2017

1 reference

13 August 2017

1 reference

Bacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

The Ins and Outs of Anthrax Toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Anthrax toxin: receptor binding, internalization, pore formation, and translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Generation of protective immune response against anthrax by oral immunization with protective antigen plant-based vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Anthrax vaccine powder formulations for nasal mucosal delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Stable dry powder formulation for nasal delivery of anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Plant molecular pharming for the treatment of chronic and infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Plants as bioreactors for the production of vaccine antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Plant-made vaccines for humans and animals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Green factory: plants as bioproduction platforms for recombinant proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Posttranslational modification of therapeutic proteins in plants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Is new always better than old?: The development of human vaccines for anthrax.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Stabilization of HAC1 influenza vaccine by spray drying: formulation development and process scale-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.009

10.1016/J.VACCINE.2016.12.009

7 January 2021

Identifiers

DOI

1 reference

13 August 2017

1 reference